Are There Any Resistance Issues with Folate Analogues?
Yes, resistance to folate analogues can occur and is a significant challenge in cancer treatment. Mechanisms of resistance may include mutations in the target enzyme DHFR, increased expression of DHFR, and alterations in drug transport mechanisms. Combination therapy and the development of newer folate analogues aim to overcome these resistance issues.
